TY - JOUR
T1 - Efficient solubilization of inclusion bodies
AU - Freydell, Esteban J.
AU - Ottens, Marcel
AU - Eppink, Michel
AU - van Dedem, Gijs
AU - van der Wielen, Luuk
PY - 2007/6
Y1 - 2007/6
N2 - The overexpression of recombinant proteins in Escherichia coli leads in most cases to their accumulation in the form of insoluble aggregates referred to as inclusion bodies (IBs). To obtain an active product, the IBs must be solubilized and thereafter the soluble monomeric protein needs to be refolded. In this work we studied the solubilization behavior of a model-protein expressed as IBs at high protein concentrations, using a statistically designed experiment to determine which of the process parameters, or their interaction, have the greatest impact on the amount of soluble protein and the fraction of soluble monomer. The experimental methodology employed pointed out an optimum balance between maximum protein solubility and minimum fraction of soluble aggregates. The optimized conditions solubilized the IBs without the formation of insoluble aggregates; moreover, the fraction of soluble monomer was ∼75% while the fraction of soluble aggregates was ∼5%. Overall this approach guarantees a better use of the solubilization reagents, which brings an economical and technical benefit, at both large and lab scale and may be broadly applicable for the production of recombinant proteins.
AB - The overexpression of recombinant proteins in Escherichia coli leads in most cases to their accumulation in the form of insoluble aggregates referred to as inclusion bodies (IBs). To obtain an active product, the IBs must be solubilized and thereafter the soluble monomeric protein needs to be refolded. In this work we studied the solubilization behavior of a model-protein expressed as IBs at high protein concentrations, using a statistically designed experiment to determine which of the process parameters, or their interaction, have the greatest impact on the amount of soluble protein and the fraction of soluble monomer. The experimental methodology employed pointed out an optimum balance between maximum protein solubility and minimum fraction of soluble aggregates. The optimized conditions solubilized the IBs without the formation of insoluble aggregates; moreover, the fraction of soluble monomer was ∼75% while the fraction of soluble aggregates was ∼5%. Overall this approach guarantees a better use of the solubilization reagents, which brings an economical and technical benefit, at both large and lab scale and may be broadly applicable for the production of recombinant proteins.
KW - Experimental design
KW - Inclusion bodies
KW - Reducing agents
KW - Solubilization
KW - Urea
UR - http://www.scopus.com/inward/record.url?scp=34447329274&partnerID=8YFLogxK
U2 - 10.1002/biot.200700046
DO - 10.1002/biot.200700046
M3 - Article
C2 - 17492713
AN - SCOPUS:34447329274
SN - 1860-6768
VL - 2
SP - 678
EP - 684
JO - Biotechnology Journal
JF - Biotechnology Journal
IS - 6
ER -